MyoKardia (MYOK) Reports Q2 Loss of $0.41/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
MyoKardia (MYOK) Prices 3.5M Share Offering at $35/Sh
August 9, 2017 5:54 AM EDTMyoKardia, Inc. (NASDAQ: MYOK) today announced the pricing of an underwritten public offering of 3,500,000 shares of its common stock at a public offering price of $35.50 per share, before underwriting discounts. In addition, the underwriters have a 30-day option to purchase an additional 525,000... More
MyoKardia (MYOK) PT Raised to $48 at Wells Fargo
August 7, 2017 10:34 AM EDTWells Fargo raised its price target on MyoKardia (NASDAQ: MYOK) to $48.00 (from $31.00) while maintaining a Outperform rating.
Analyst Jim Birchenough comments "We believe results were better than expected and should bode well for phase 3 success in the planned EXPLORER study. We... More
